Ursa Health PQA Module

Overview

The foundational measures in the Ursa Health PQA Module are Pharmacy Quality Alliance (PQA) and Stars implementations covering medication adherence, appropriate medication, and medication safety. These measures are generated at the patient-level and provide document-level details for measure numerator and denominator criteria.

In additional to the per-the-specifications measures, the PQA Module delivers analytics to support improvement work including: A registry of all medication fills; the ability to narrow measure results to an actionable patient list; and comparisons to results generated externally.

Release Notes

• Ursa Health PQA Module Release Notes

Reports

No articles found in this category.

Objects

• Data Mart Objects

  • [DM/URSA-PQA] Data Mart for Consolidated PQA Measure Outputs, Precursor 1
  • [DM/URSA-PQA] Data Mart for Consolidated PQA Measure Results
  • [DM/URSA-PQA] Data Mart for Consolidated STARS Measure Results
  • [DM/URSA-PQA] Data Mart for Consolidated STARs Measure Outputs, Precursor 1
  • [DM/URSA-PQA] Data Mart for PQA Patient Timeline Localized Concepts
  • [DM/URSA-PQA] Data Mart for URSA-PQA Medication Outpatient Fills

• Measure Objects

  • [MO/URSA-PQA] URSA-PQA-COB: Concurrent Use: Opioids and Benzodiazepines (COB)
  • [MO/URSA-PQA] URSA-PQA-PDC-DR: Diabetes All Class (PDC-DR)
  • [MO/URSA-PQA] URSA-PQA-PDC-RASA: Renin Angiotensin System Antagonists (PDC-RASA)
  • [MO/URSA-PQA] URSA-PQA-PDC-STA: Statins (PDC-STA)
  • [MO/URSA-PQA] URSA-PQA-POLYACH: Multi Anticholinergic Meds in Adults (POLYACH)
  • [MO/URSA-PQA] URSA-PQA-STARS-D08: D08: Medication Adherence for Diabetes Medications
  • [MO/URSA-PQA] URSA-PQA-STARS-D09: D09: Med Adherence for HTN (RAS antagonists)
  • [MO/URSA-PQA] URSA-PQA-STARS-D10: D10: Medication Adherence for Statin Medications
  • [MO/URSA-PQA] URSA-PQA-STARS-D12: D12: Statins for Patients With Diabetes (SUPD)
  • [MO/URSA-PQA] URSA-PQA-SUPD: Statin Therapy for Patients With Diabetes (SUPD)

• Synthetic Objects

  • [SO/URSA-PQA] All Class Anticholinergic In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] All Class Anticholinergic In-Supply Periods
  • [SO/URSA-PQA] All Class Anticholinergic In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class Benzodiazepines In-Supply Periods
  • [SO/URSA-PQA] All Class Benzodiazepines In-Supply Periods with Current Membership
  • [SO/URSA-PQA] All Class Benzodiazepines In-Supply Periods with Current Membership, Precursor 3 (Episode Fills)
  • [SO/URSA-PQA] All Class Benzodiazepines In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class Benzodiazepines In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] All Class Diabetes In-Supply Periods
  • [SO/URSA-PQA] All Class Diabetes In-Supply Periods with Current Membership, Precursor 3 (Episode Fills)
  • [SO/URSA-PQA] All Class Diabetes In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class Diabetes In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] All Class Opioid In-Supply Periods
  • [SO/URSA-PQA] All Class Opioid In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] All Class Opioids In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class RASA In-Supply Periods
  • [SO/URSA-PQA] All Class RASA In-Supply Periods with Current Membership
  • [SO/URSA-PQA] All Class RASA In-Supply Periods with Current Membership, Precursor 3 (Episode Fills)
  • [SO/URSA-PQA] All Class RASA In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class RASA In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] All Class Statin In-Supply Periods
  • [SO/URSA-PQA] All Class Statin In-Supply Periods with Current Membership
  • [SO/URSA-PQA] All Class Statin In-Supply Periods with Current Membership, Precursor 3 (Episode Fills)
  • [SO/URSA-PQA] All Class Statin In-Supply Periods, Precursor 1 (Fills)
  • [SO/URSA-PQA] All Class Statin In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] Document Aggregator for URSA-PQA Concepts
  • [SO/URSA-PQA] Outpatient Fills for URSA-PQA Medications
  • [SO/URSA-PQA] Patient Timelines Master for URSA-PQA Concepts
  • [SO/URSA-PQA] STARS All Class RASA In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] Stars All Class Diabetes In-Supply Periods with Current Membership
  • [SO/URSA-PQA] Stars All Class Diabetes In-Supply Periods, Precursor 2 (Episode Fills)
  • [SO/URSA-PQA] Timeline of Overlapping Anticholinergic
  • [SO/URSA-PQA] Timeline of Overlapping Opioid and Benzodiazepines

Measures

• URSA-PQA-COB: Concurrent Use: Opioids and Benzodiazepines (COB)
• URSA-PQA-PDC-DR: Diabetes All Class (PDC-DR)
• URSA-PQA-PDC-RASA: Renin Angiotensin System Antagonists (PDC-RASA)
• URSA-PQA-PDC-STA: Statins (PDC-STA)
• URSA-PQA-POLYACH: Multi Anticholinergic Meds in Adults (POLYACH)
• URSA-PQA-R01: PQA Targeted Medication Fills
• URSA-PQA-STARS-D08: D08: Medication Adherence for Diabetes Medications
• URSA-PQA-STARS-D09: D09: Med Adherence for HTN (RAS antagonists)
• URSA-PQA-STARS-D10: D10: Medication Adherence for Statin Medications
• URSA-PQA-STARS-D12: D12: Statins for Patients With Diabetes (SUPD)
• URSA-PQA-SUPD: Statin Therapy for Patients With Diabetes (SUPD)